Figure 4From: The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical studyGlucose fluctuations difference between maximum and minimum glucose levels in SMBG. Mitiglinide but not glimepiride improved postprandial glucose level by SMBG.Back to article page